nCovid-19 Update

Daktari Biotechnology approach to addressing the nCovid-19 pandemic is currently focused on developing a subunit spike protein or VLP vaccine, an interferon-based prophylactic and a small molecule compound. Work on these programs has been initiated through CROs and this approach will be pursued while the company's R & D facilities get established.